|
|
Volumn 26, Issue 11, 2008, Pages 1213-1215
|
|
Breaching the barrier
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AL 108;
AL 208;
ANG 1005;
ANTIDEPRESSANT AGENT;
ANTINEOPLASTIC AGENT;
CANNABINOID;
GABAPENTIN;
GLUCOSE TRANSPORTER 1;
INSULIN;
LEPTIN;
LEVODOPA;
NETAMIFTIDE;
NEUROLEPTIC AGENT;
PACLITAXEL;
PREGABALIN;
SCORPION VENOM;
SOLZIRA;
SOMATOMEDIN;
TM 601;
UNCLASSIFIED DRUG;
XP 21279;
ASTROCYTE;
BLOOD BRAIN BARRIER;
BRAIN FUNCTION;
BRAIN NERVE CELL;
BRAIN TUMOR;
CLINICAL TRIAL;
COGNITIVE DEFECT;
DEPRESSION;
DRUG ABSORPTION;
DRUG ACTIVITY;
DRUG DISTRIBUTION;
DRUG INDUSTRY;
ENDOTHELIUM CELL;
EPILEPSY;
GLIOBLASTOMA;
GLIOMA;
HUMAN;
NEUROLOGIC DISEASE;
NONHUMAN;
NOTE;
PARKINSON DISEASE;
PERICYTE;
PRIORITY JOURNAL;
SEIZURE;
BIOMEDICAL RESEARCH;
BIOTECHNOLOGY;
BLOOD-BRAIN BARRIER;
BRAIN DISEASES;
BRAIN NEOPLASMS;
CLINICAL TRIALS AS TOPIC;
GLIOMA;
HUMANS;
IODINE RADIOISOTOPES;
NEUROPEPTIDES;
PHARMACEUTICAL PREPARATIONS;
SCORPION VENOMS;
|
|
EID: 55749084894
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt1108-1213 Document Type: Note |
|
Times cited : (19)
|
|
References (0)
|
